US Stock MarketDetailed Quotes

BXPHF BOTANIX PHARMACEUTICALS LTD

Watchlist
  • 0.271
  • 0.0000.00%
15min DelayClose Sep 9 16:00 ET
491.60MMarket Cap-45166P/E (TTM)

BOTANIX PHARMACEUTICALS LTD Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
Total revenue
484.67%601.82K
102.93K
Operating revenue
484.67%601.82K
--102.93K
----
----
----
----
Cost of revenue
Gross profit
484.67%601.82K
102.93K
Operating expense
24.52%16.06M
-19.08%12.9M
55.26%15.94M
-57.68%10.27M
13.05%24.26M
21.46M
Selling and administrative expenses
129.70%6.98M
-14.55%3.04M
58.49%3.56M
-72.81%2.24M
158.80%8.25M
--3.19M
-Selling and marketing expense
--331.31K
----
----
----
----
----
-General and administrative expense
118.80%6.65M
-14.55%3.04M
58.49%3.56M
-72.81%2.24M
158.80%8.25M
--3.19M
Research and development costs
-68.35%1.81M
-44.35%5.73M
56.63%10.29M
-52.03%6.57M
-17.63%13.7M
--16.63M
Depreciation amortization depletion
-34.25%72.61K
-23.04%110.43K
52.30%143.5K
-7.88%94.22K
6,369.32%102.28K
--1.58K
-Depreciation and amortization
-34.25%72.61K
-23.04%110.43K
52.30%143.5K
-7.88%94.22K
6,369.32%102.28K
--1.58K
Other operating expenses
78.92%7.2M
106.35%4.02M
43.52%1.95M
-38.43%1.36M
34.58%2.21M
--1.64M
Operating profit
-20.82%-15.46M
19.73%-12.8M
-55.26%-15.94M
57.68%-10.27M
-13.05%-24.26M
-21.46M
Net non-operating interest income expense
512.36%65.06K
-23,806.06%-15.78K
-100.14%-66
-63.08%47.85K
13.43%129.6K
114.26K
Non-operating interest income
14.80%75.72K
76.48%65.96K
-63.99%37.37K
-42.52%103.79K
43.93%180.58K
--125.46K
Non-operating interest expense
-86.96%10.66K
118.31%81.74K
-33.07%37.44K
9.73%55.94K
354.95%50.98K
--11.21K
Other net income (expense)
-58.31%1.52M
32.02%3.66M
-59.76%2.77M
-6.94%6.89M
71.82%7.4M
4.31M
Other non- operating income (expenses)
-58.31%1.52M
32.02%3.66M
-59.76%2.77M
-6.94%6.89M
71.82%7.4M
--4.31M
Income before tax
-51.52%-13.87M
30.50%-9.15M
-295.04%-13.17M
80.07%-3.33M
1.81%-16.73M
-17.04M
Income tax
0
0
0
0
0
0
Net income
-51.52%-13.87M
30.50%-9.15M
-295.04%-13.17M
80.07%-3.33M
1.81%-16.73M
-17.04M
Net income continuous Operations
-51.52%-13.87M
30.50%-9.15M
-295.04%-13.17M
80.07%-3.33M
1.81%-16.73M
---17.04M
Minority interest income
Net income attributable to the parent company
-51.52%-13.87M
30.50%-9.15M
-295.04%-13.17M
80.07%-3.33M
1.81%-16.73M
-17.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-51.52%-13.87M
30.50%-9.15M
-295.04%-13.17M
80.07%-3.33M
1.81%-16.73M
-17.04M
Basic earnings per share
-16.46%-0.0092
41.48%-0.0079
-297.06%-0.0135
81.01%-0.0034
20.09%-0.0179
-0.0224
Diluted earnings per share
-16.46%-0.0092
41.48%-0.0079
-297.06%-0.0135
81.01%-0.0034
20.09%-0.0179
-0.0224
Dividend per share
Currency Unit
AUD
AUD
AUD
AUD
AUD
AUD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019
Total revenue 484.67%601.82K102.93K
Operating revenue 484.67%601.82K--102.93K----------------
Cost of revenue
Gross profit 484.67%601.82K102.93K
Operating expense 24.52%16.06M-19.08%12.9M55.26%15.94M-57.68%10.27M13.05%24.26M21.46M
Selling and administrative expenses 129.70%6.98M-14.55%3.04M58.49%3.56M-72.81%2.24M158.80%8.25M--3.19M
-Selling and marketing expense --331.31K--------------------
-General and administrative expense 118.80%6.65M-14.55%3.04M58.49%3.56M-72.81%2.24M158.80%8.25M--3.19M
Research and development costs -68.35%1.81M-44.35%5.73M56.63%10.29M-52.03%6.57M-17.63%13.7M--16.63M
Depreciation amortization depletion -34.25%72.61K-23.04%110.43K52.30%143.5K-7.88%94.22K6,369.32%102.28K--1.58K
-Depreciation and amortization -34.25%72.61K-23.04%110.43K52.30%143.5K-7.88%94.22K6,369.32%102.28K--1.58K
Other operating expenses 78.92%7.2M106.35%4.02M43.52%1.95M-38.43%1.36M34.58%2.21M--1.64M
Operating profit -20.82%-15.46M19.73%-12.8M-55.26%-15.94M57.68%-10.27M-13.05%-24.26M-21.46M
Net non-operating interest income expense 512.36%65.06K-23,806.06%-15.78K-100.14%-66-63.08%47.85K13.43%129.6K114.26K
Non-operating interest income 14.80%75.72K76.48%65.96K-63.99%37.37K-42.52%103.79K43.93%180.58K--125.46K
Non-operating interest expense -86.96%10.66K118.31%81.74K-33.07%37.44K9.73%55.94K354.95%50.98K--11.21K
Other net income (expense) -58.31%1.52M32.02%3.66M-59.76%2.77M-6.94%6.89M71.82%7.4M4.31M
Other non- operating income (expenses) -58.31%1.52M32.02%3.66M-59.76%2.77M-6.94%6.89M71.82%7.4M--4.31M
Income before tax -51.52%-13.87M30.50%-9.15M-295.04%-13.17M80.07%-3.33M1.81%-16.73M-17.04M
Income tax 000000
Net income -51.52%-13.87M30.50%-9.15M-295.04%-13.17M80.07%-3.33M1.81%-16.73M-17.04M
Net income continuous Operations -51.52%-13.87M30.50%-9.15M-295.04%-13.17M80.07%-3.33M1.81%-16.73M---17.04M
Minority interest income
Net income attributable to the parent company -51.52%-13.87M30.50%-9.15M-295.04%-13.17M80.07%-3.33M1.81%-16.73M-17.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -51.52%-13.87M30.50%-9.15M-295.04%-13.17M80.07%-3.33M1.81%-16.73M-17.04M
Basic earnings per share -16.46%-0.009241.48%-0.0079-297.06%-0.013581.01%-0.003420.09%-0.0179-0.0224
Diluted earnings per share -16.46%-0.009241.48%-0.0079-297.06%-0.013581.01%-0.003420.09%-0.0179-0.0224
Dividend per share
Currency Unit AUDAUDAUDAUDAUDAUD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data